Search

everythinglearnresearchcommunity

for

Search:↓

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

PRP injections can effectively treat alopecia areata.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

One child resisted treatment, while the other was successfully treated for scalp ringworm.

A family had a rare fungal infection called white piedra, identified as Trichosporon inkin.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

IL-1β inhibits human hair follicle growth.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Injecting CD34+ cell-containing platelet-rich plasma into the scalp can improve hair count and thickness in people with pattern hair loss.

Tick bites may cause hair loss due to inflammation from tick saliva.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The treatment was effective for advanced non-Hodgkin's lymphomas.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

Entospletinib effectively prevents eye and skin GVHD in mice.

A simple test can help diagnose a rare bruising disorder after ruling out other causes.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.